|  | Cancer | Skin Cancer

Vitiligo and Skin Cancer Risk: UV Vulnerability and Photoprotection Strategies

Elevated Risk Mechanism

Depigmented skin lacks melanin, the primary chromophore that absorbs and scatters UV radiation. This results in:

  • Reduced minimal erythema dose (MED) → sunburn at lower UV exposure.
  • Increased DNA damage (cyclobutane pyrimidine dimers) in keratinocytes.
  • Impaired immune surveillance (Langerhans cell dysfunction in vitiliginous skin).

Epidemiologic Evidence

  • Meta-analyses show 2–3 fold increased risk of melanoma and non-melanoma skin cancer (SCC, BCC) in vitiligo patients.
  • Risk highest in: fair skin (Fitzpatrick I–II), extensive BSA involvement, history of phototherapy (PUVA > NB-UVB), immunosuppression.
  • Paradox: Some studies suggest NB-UVB does not significantly increase SCC/BCC risk; PUVA does.

Photoprotection Protocol

  1. Broad-spectrum SPF 50+ daily (UVA-PF ≥1/3 SPF). Reapply 2-hourly outdoors.
  2. Photoprotective clothing: UPF 50+ shirts, wide-brim hats, UV-blocking sunglasses.
  3. Avoid peak UV: 10 AM – 4 PM (or when UV index ≥3).
  4. Shade-seeking behavior.
  5. No tanning beds.

Surveillance

  • Annual total-body skin exam by dermatologist.
  • Patient self-exam monthly (ABCDE for melanoma; new/changing lesions).
  • Dermoscopy for equivocal lesions.
  • Consider baseline photography for extensive vitiligo.

Special Considerations

  • Phototherapy patients: Cumulative UV dose tracking; annual skin exam mandatory.
  • Pediatric vitiligo: Lifelong UV protection critical; childhood sunburns strongly linked to melanoma.
  • Repigmented skin: Remains UV-sensitive; continue protection.

Skin Cancer - Related Articles